| Michael Albert Christensen, OD | |
|
3455 Vestal Pkwy E, Vestal, NY 13850-2134 | |
| (607) 722-2020 | |
| (607) 722-3937 |
| Full Name | Michael Albert Christensen |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 5 Years |
| Location | 3455 Vestal Pkwy E, Vestal, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356909972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TUV009005 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York Optometry Professional Pllc | 5890169841 | 7 |
News Archive
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
Now a new study published on the preprint server medRxiv in August 2020, therefore, presents the results of a meta-analysis that takes account of the lack of compliance with mask-wearing in RCTs, as well as the lag between the event and the measurable effects.
A team of researchers at the University of Edinburgh, UK, suggest that consistent mask-wearing is associated with better wellbeing.
Solar energy has long been used as a clean alternative to fossil fuels such as coal and oil, but it could only be harnessed during the day when the sun's rays were strongest. Now researchers led by Tom Meyer at the Energy Frontier Research Center at the University of North Carolina at Chapel Hill have built a system that converts the sun's energy not into electricity but hydrogen fuel and stores it for later use, allowing us to power our devices long after the sun goes down.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
› Verified 4 days ago
| Provider Name | Dr George T Roberts Optometrist Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1508929134 PECOS PAC ID: 1153352364 Enrollment ID: O20050827000125 |
News Archive
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
Now a new study published on the preprint server medRxiv in August 2020, therefore, presents the results of a meta-analysis that takes account of the lack of compliance with mask-wearing in RCTs, as well as the lag between the event and the measurable effects.
A team of researchers at the University of Edinburgh, UK, suggest that consistent mask-wearing is associated with better wellbeing.
Solar energy has long been used as a clean alternative to fossil fuels such as coal and oil, but it could only be harnessed during the day when the sun's rays were strongest. Now researchers led by Tom Meyer at the Energy Frontier Research Center at the University of North Carolina at Chapel Hill have built a system that converts the sun's energy not into electricity but hydrogen fuel and stores it for later use, allowing us to power our devices long after the sun goes down.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
› Verified 4 days ago
| Provider Name | Roberts & Roberts |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427120906 PECOS PAC ID: 9739106477 Enrollment ID: O20051101000427 |
News Archive
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
Now a new study published on the preprint server medRxiv in August 2020, therefore, presents the results of a meta-analysis that takes account of the lack of compliance with mask-wearing in RCTs, as well as the lag between the event and the measurable effects.
A team of researchers at the University of Edinburgh, UK, suggest that consistent mask-wearing is associated with better wellbeing.
Solar energy has long been used as a clean alternative to fossil fuels such as coal and oil, but it could only be harnessed during the day when the sun's rays were strongest. Now researchers led by Tom Meyer at the Energy Frontier Research Center at the University of North Carolina at Chapel Hill have built a system that converts the sun's energy not into electricity but hydrogen fuel and stores it for later use, allowing us to power our devices long after the sun goes down.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
› Verified 4 days ago
| Provider Name | New York Optometry Professional Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1598470544 PECOS PAC ID: 5890169841 Enrollment ID: O20230315000804 |
News Archive
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
Now a new study published on the preprint server medRxiv in August 2020, therefore, presents the results of a meta-analysis that takes account of the lack of compliance with mask-wearing in RCTs, as well as the lag between the event and the measurable effects.
A team of researchers at the University of Edinburgh, UK, suggest that consistent mask-wearing is associated with better wellbeing.
Solar energy has long been used as a clean alternative to fossil fuels such as coal and oil, but it could only be harnessed during the day when the sun's rays were strongest. Now researchers led by Tom Meyer at the Energy Frontier Research Center at the University of North Carolina at Chapel Hill have built a system that converts the sun's energy not into electricity but hydrogen fuel and stores it for later use, allowing us to power our devices long after the sun goes down.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Albert Christensen, OD 3455 Vestal Pkwy E, Vestal, NY 13850-2134 Ph: (607) 722-2020 | Michael Albert Christensen, OD 3455 Vestal Pkwy E, Vestal, NY 13850-2134 Ph: (607) 722-2020 |
News Archive
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
Now a new study published on the preprint server medRxiv in August 2020, therefore, presents the results of a meta-analysis that takes account of the lack of compliance with mask-wearing in RCTs, as well as the lag between the event and the measurable effects.
A team of researchers at the University of Edinburgh, UK, suggest that consistent mask-wearing is associated with better wellbeing.
Solar energy has long been used as a clean alternative to fossil fuels such as coal and oil, but it could only be harnessed during the day when the sun's rays were strongest. Now researchers led by Tom Meyer at the Energy Frontier Research Center at the University of North Carolina at Chapel Hill have built a system that converts the sun's energy not into electricity but hydrogen fuel and stores it for later use, allowing us to power our devices long after the sun goes down.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
› Verified 4 days ago
Dr. Robert Andrew Vititow, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2441 Vestal Parkway East, Sam's Club, Vestal, NY 13850 Phone: 607-770-6297 Fax: 607-766-8592 | |
Glenn Allen Coffin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2421 Vestal Pkwy E Ste 5, Vestal, NY 13850 Phone: 607-217-5169 | |
Dr. Zachary Kyle Bird, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2421 Vestal Pkwy E # 5, Vestal, NY 13850 Phone: 607-217-5169 | |
Dr. Ronald Austin Meeker, OD Optometrist Medicare: Medicare Enrolled Practice Location: 157 Front St, Vestal, NY 13850 Phone: 607-754-4426 Fax: 607-754-0464 | |
Dr. George Templeton Roberts, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 3455 Vestal Pkwy E, Vestal, NY 13850 Phone: 607-722-2020 Fax: 607-722-3937 | |
Dr. Wade Fiegl, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3455 Vestal Pkwy E, Vestal, NY 13850 Phone: 607-722-2020 | |
Dr. Heather Marie Beierle, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3900 Vestal Pky E, Empire Vision Centers, Vestal, NY 13850 Phone: 607-771-1212 Fax: 607-729-2605 |